StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)

Close on Nov 17, 2026Market cap $484.35MP/E –Yield –

Carlsmed gross margin

Gross margin is gross profit as a percentage of revenue.

Carlsmed's gross margin for the twelve months ending Jun 30, 2026 was 76.6%. For fiscal 2025 it was 75.3%, against 73.8% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202575.3%+1.5
FY2024Dec 31, 202473.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202676.8%+3.4
Q1 FY2026Mar 31, 202677.1%+2.2
Q4 FY2025Dec 31, 202576.5%+1.9
Q3 FY2025Sep 30, 202575.9%+3.1
Q2 FY2025Jun 30, 202573.4%−1.6
Q1 FY2025Mar 31, 202574.9%–
Q4 FY2024Dec 31, 202474.7%–
Q3 FY2024Sep 30, 202472.8%–
Q2 FY2024Jun 30, 202475.0%–

More Carlsmed figures

See a number that looks wrong?